Skip to main content

Table 1 Baseline clinical characteristic, lipid concentrations in the study groups

From: Elevated levels of preβ1-high-density lipoprotein are associated with cholesterol ester transfer protein, the presence and severity of coronary artery disease

Variable

ACS

(n = 88)

SCAD

(n = 79)

Control

(n = 85)

Age (y)

64.52 ± 12.04

67.42 ± 13.34

63.79 ± 13.17

Male/female

62/26

56/23

64/21

Hypertension (%)

59 (67%)

62 (78%)

0 (0)

Ischemic stroke (%)

32 (36%)

24 (30%)

0 (0)

Diabetes mellitus (%)

39 (44%)

30 (38%)

0 (0)

Medication

   

 Statins, n (%)

48 (54.5)

25 (31.6)

0 (0)

 ACEI/ARB, n (%)

63 (71.6)

51 (64.6)

0 (0)

 Beta blockers, n (%)

58 (65.9)

42 (53.2)

0 (0)

 Aspirin (%)

60 (68.2)

26.2 (21.0)

0 (0)

Angiographic analysis

   

 Maximal stenosis (%)

89.34 ± 15.62**

23.87

-

 Number of vessel disease

2.04 ± 0.85

1.14 ± 0.93

-

cTnI, ng/L

19.42 ± 71.19**

0.03 ± 0.02

-

CK-MB, U/L

75.42 ± 126.14**

11.68 ± 4.12

 

Gensini score

62.23 ± 41.58**

17.20 ± 18.39

-

  1. Data are presented as the mean ± SD or number (%) of subjects
  2. Compared with SCAD: * P < 0.05, ** P < 0.01